Skip to main content
InterCure Ltd. (INCR)
NASDAQ: INCR · IEX Real-Time Price · USD
2.650
0.00 (0.00%)
At close: Apr 26, 2024, 4:00 PM
2.670
+0.020 (0.75%)
After-hours: Apr 26, 2024, 7:24 PM EDT

InterCure Revenue

InterCure had revenue of $112.41M in the twelve months ending June 30, 2023, with 20.43% growth year-over-year. Revenue in the quarter ending June 30, 2023 was $27.76M with 1.11% year-over-year growth. In the year 2022, InterCure had annual revenue of $109.80M with 59.94% growth.

Revenue (ttm)
$112.41M
Revenue Growth
+20.43%
P/S Ratio
1.08
Revenue / Employee
$303,810
Employees
370
Market Cap
121.22M USD

Revenue Chart

* The company reports in ILS currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2022109.80M41.15M59.94%
Dec 31, 202168.65M48.33M237.78%
Dec 31, 202020.32M17.77M696.91%
Dec 31, 20192.55M--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Amylyx Pharmaceuticals 380.79M
TruBridge 339.44M
Karyopharm Therapeutics 146.03M
Outset Medical 130.38M
Seres Therapeutics 126.33M
Xtant Medical Holdings 91.30M
Seer, Inc. 16.66M
Revenue Rankings

INCR News

More News